TABLE 1.
HPV prevalence and disease outcome by age group and colposcopy centersa
| Cervical hrHPV | Vaginal first BD Viper LT hrHPV |
Vaginal second BD Viper LT hrHPV | Vaginal second BD COR hrHPV |
Disease outcome | |||||
|---|---|---|---|---|---|---|---|---|---|
| Age category (years) |
Participants N (%) |
Pos N (%) |
Pos N (%) |
Pos N (%) |
Pos N (%) |
≤CIN1 N (%) |
≥CIN2 N (%) |
≥CIN3 N (%) |
|
| <30 | 46 (15.9) | 38 (19.9) | 39 (19.0) | 39 (18.5) | 39 (18.9) | 27 (13.0) | 19 (22.9) | 12 (25.0) | |
| 30–39 | 96 (33.1) | 64 (33.5) | 73 (35.6) | 75 (35.6) | 71 (34.5) | 66 (31.9) | 30 (36.1) | 19 (39.6) | |
| 40–49 | 81 (27.9) | 52 (27.2) | 51 (24.9) | 56 (26.5) | 55 (26.7) | 58 (28.0) | 23 (27.7) | 14 (29.2) | |
| 50–59 | 57 (19.7) | 31 (16.2) | 35 (17.1) | 35 (16.6) | 35 (17.0) | 48 (23.2) | 9 (10.8) | 1 (2.1) | |
| 60+ | 10 (3.5) | 6 (3.1) | 7 (3.4) | 6 (2.8) | 6 (2.9) | 8 (3.9) | 2 (2.4) | 2 (4.2) | |
| Total | 290 (100.0) | 191 (100.0) | 205 (100.0) | 211 (100.0) | 206 (100.0) | 207 (100.0) | 83 (100.0) | 48 (100.0) | |
a
CIN, cervical intraepithelial neoplasia.